Huerta-Yepez, S., Gonzalez, J. D., Sheik, N., Beraki, S., Kathirvel, E., Rodriguez-Frandsen, A., . . . Jewett, A. (2025). Therapeutic Efficacy of CD34-Derived Allogeneic Dendritic Cells Engineered to Express CD93, CD40L, and CXCL13 in Humanized Mouse Models of Pancreatic Cancer. MDPI AG.
Chicago Style (17th ed.) CitationHuerta-Yepez, Sara, et al. Therapeutic Efficacy of CD34-Derived Allogeneic Dendritic Cells Engineered to Express CD93, CD40L, and CXCL13 in Humanized Mouse Models of Pancreatic Cancer. MDPI AG, 2025.
MLA (9th ed.) CitationHuerta-Yepez, Sara, et al. Therapeutic Efficacy of CD34-Derived Allogeneic Dendritic Cells Engineered to Express CD93, CD40L, and CXCL13 in Humanized Mouse Models of Pancreatic Cancer. MDPI AG, 2025.
Warning: These citations may not always be 100% accurate.